Long-term outcome of renal transplantation in patients with systemic lupus erythematosus. 1989

G L Bumgardner, and S M Mauer, and N L Ascher, and W D Payne, and D L Dunn, and D S Fryd, and D E Sutherland, and R L Simmons, and J S Najarian
Department of Surgery, University of Minnesota, Minneapolis 55455.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G L Bumgardner, and S M Mauer, and N L Ascher, and W D Payne, and D L Dunn, and D S Fryd, and D E Sutherland, and R L Simmons, and J S Najarian
June 2003, Transplant international : official journal of the European Society for Organ Transplantation,
G L Bumgardner, and S M Mauer, and N L Ascher, and W D Payne, and D L Dunn, and D S Fryd, and D E Sutherland, and R L Simmons, and J S Najarian
August 1997, Seminars in arthritis and rheumatism,
G L Bumgardner, and S M Mauer, and N L Ascher, and W D Payne, and D L Dunn, and D S Fryd, and D E Sutherland, and R L Simmons, and J S Najarian
December 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
G L Bumgardner, and S M Mauer, and N L Ascher, and W D Payne, and D L Dunn, and D S Fryd, and D E Sutherland, and R L Simmons, and J S Najarian
November 1983, Archives of internal medicine,
G L Bumgardner, and S M Mauer, and N L Ascher, and W D Payne, and D L Dunn, and D S Fryd, and D E Sutherland, and R L Simmons, and J S Najarian
June 1993, Transplantation proceedings,
G L Bumgardner, and S M Mauer, and N L Ascher, and W D Payne, and D L Dunn, and D S Fryd, and D E Sutherland, and R L Simmons, and J S Najarian
April 2021, International journal of clinical practice,
G L Bumgardner, and S M Mauer, and N L Ascher, and W D Payne, and D L Dunn, and D S Fryd, and D E Sutherland, and R L Simmons, and J S Najarian
January 1981, Nephron,
G L Bumgardner, and S M Mauer, and N L Ascher, and W D Payne, and D L Dunn, and D S Fryd, and D E Sutherland, and R L Simmons, and J S Najarian
January 1977, Proceedings of the Clinical Dialysis and Transplant Forum,
G L Bumgardner, and S M Mauer, and N L Ascher, and W D Payne, and D L Dunn, and D S Fryd, and D E Sutherland, and R L Simmons, and J S Najarian
May 2013, BMC research notes,
G L Bumgardner, and S M Mauer, and N L Ascher, and W D Payne, and D L Dunn, and D S Fryd, and D E Sutherland, and R L Simmons, and J S Najarian
August 1999, Arthritis and rheumatism,
Copied contents to your clipboard!